107 related articles for article (PubMed ID: 10089709)
1. [Ebrotidine-induced acute hepatitis].
Rausell V; Hallal H; Salinas E; Pérez-Gracia A
Gastroenterol Hepatol; 1999 Jan; 22(1):28. PubMed ID: 10089709
[No Abstract] [Full Text] [Related]
2. [Toxic hepatitis caused by ebrotidine].
Castellote J; Porta F
Med Clin (Barc); 1998 Nov; 111(17):676. PubMed ID: 9881355
[No Abstract] [Full Text] [Related]
3. [Hepatoxicity due to ebrotidine: report of two cases].
Quílez C; Palazón JM; Jover R; Martínez R; Chuliá T; Griñó P; Belda G
Gastroenterol Hepatol; 1999 Oct; 22(8):434-5. PubMed ID: 10592681
[No Abstract] [Full Text] [Related]
4. Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine.
Pineda JA; Larrauri J; Macías J; Hernández A; Guijarro J; Sayago M; Gavilán F; Aguilar J; Lissen E
J Hepatol; 1999 Oct; 31(4):777-8. PubMed ID: 10551406
[No Abstract] [Full Text] [Related]
5. Liver injury caused by ebrotidine: a new example of the utility of the postmarketing surveillance.
Castillo JR; Torelló J; Hernandez A
Eur J Clin Pharmacol; 2000 May; 56(2):187-9. PubMed ID: 10877015
[No Abstract] [Full Text] [Related]
6. Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist.
Andrade RJ; Lucena MI; Martin-Vivaldi R; Fernandez MC; Nogueras F; Pelaez G; Gomez-Outes A; Garcia-Escaño MD; Bellot V; Hervás A; Cárdenas F; Bermudez F; Romero M; Salmerón J
J Hepatol; 1999 Oct; 31(4):641-6. PubMed ID: 10551387
[TBL] [Abstract][Full Text] [Related]
7. Allergic dermatitis due to oral ebrotidine.
Carretero Aníbarro P; Blanco Carmona J; García González F; Garcés Sotillos M; Herrero Gil D; Pérez Giménez R; Juste Picón S
J Investig Allergol Clin Immunol; 1999; 9(3):193-4. PubMed ID: 10412683
[TBL] [Abstract][Full Text] [Related]
8. Acute cholestatic hepatitis in a child treated with famotidine.
Jiménez-Sáenz M; Argüelles-Arias F; Herrerías-Gutiérrez JM; Durán-Quintana JA
Am J Gastroenterol; 2000 Dec; 95(12):3665-6. PubMed ID: 11151926
[No Abstract] [Full Text] [Related]
9. Ranitidine induced hepatitis.
Lee TH; Vega KJ; El Khoury JG
J Gastrointestin Liver Dis; 2010 Sep; 19(3):337-8. PubMed ID: 20922203
[No Abstract] [Full Text] [Related]
10. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
11. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
Agut J; Sánchez JC; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
[TBL] [Abstract][Full Text] [Related]
12. Possible cholestatic injury from ranitidine with a review of the literature.
Ramrakhiani S; Brunt EM; Bacon BR
Am J Gastroenterol; 1998 May; 93(5):822-6. PubMed ID: 9625136
[TBL] [Abstract][Full Text] [Related]
13. Ebrotidine--a new H2-receptor antagonist with mucosal strengthening activity.
Piotrowski J; Yamaki K; Morita M; Slomiany A; Slomiany BL
Biochem Int; 1992 Mar; 26(4):659-67. PubMed ID: 1351724
[TBL] [Abstract][Full Text] [Related]
14. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
[TBL] [Abstract][Full Text] [Related]
15. Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans.
Maczka M; Kwiecień N; Obtułowicz W; Konturek SJ; Kamiński K; Oleksy J; Gabryelewicz A; Torres J
J Physiol Pharmacol; 1992 Jun; 43(2):139-48. PubMed ID: 1356519
[TBL] [Abstract][Full Text] [Related]
16. Ebrotidine. A new generation H2-receptor antagonist and gastroprotective agent. Introduction.
Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):427-30. PubMed ID: 9205737
[No Abstract] [Full Text] [Related]
17. Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 1999 Sep; 50(3):391-404. PubMed ID: 10574469
[TBL] [Abstract][Full Text] [Related]
18. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
[TBL] [Abstract][Full Text] [Related]
19. Metabolites of ebrotidine, a new H2-receptor antagonist, in human urine.
Rozman E; Galcerán MT; Anglada L; Albet C
J Pharm Sci; 1994 Feb; 83(2):252-4. PubMed ID: 7909553
[TBL] [Abstract][Full Text] [Related]
20. [Ebrotidine].
Elizalde JI
Gastroenterol Hepatol; 1997 Feb; 20(2):65-7. PubMed ID: 9072206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
